tyrphostin ag 1024 has been researched along with Hyperplasia, Reactive Lymphoid in 1 studies
tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, X | 2 |
| Chen, N | 1 |
| Xu, H | 1 |
| Wang, J | 1 |
| Fang, X | 1 |
| Zhang, Y | 1 |
| Li, Y | 1 |
| Yang, J | 1 |
| Wang, X | 1 |
1 other study available for tyrphostin ag 1024 and Hyperplasia, Reactive Lymphoid
| Article | Year |
|---|---|
Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma.
Topics: Adaptor Proteins, Signal Transducing; Aged; Animals; Apoptosis; B-Lymphocytes; Cell Cycle Checkpoint | 2020 |